07.02.2024 - CEO Dave Marver will present on the Company’s use of brain-computer interface technology and progress toward planned commercialization of ARC-EX later this yearEINDHOVEN, the Netherlands, Feb. 07, 2024 (GLOBE NEWSWIRE) - ONWARD Medical N.V. . Seite 1
18.01.2024 - HemON NL is evaluating the use of ARC-IM Therapy to address hemodynamic instability after spinal cord injuryEINDHOVEN, the Netherlands, Jan. 18, 2024 (GLOBE NEWSWIRE) - ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating . Seite 1
16.11.2023 - EINDHOVEN, the Netherlands, Nov. 16, 2023 (GLOBE NEWSWIRE) - Completing activities required for ARC-EX FDA submission Expanded HemON Study as precursor to ARC-IM Empower BP pivotal study First-in-human use of ARC-IM BCI for . Seite 1
19.09.2023 - Eindhoven, Sept. 19, 2023 (GLOBE NEWSWIRE) - THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) US commercialization of ARC-EX expected 2H 2024 with USD 30,000 . Seite 1